XENE Files NDA for Epilepsy Drug, Falls on Depression Studies’ Setback
Xenon Pharmaceuticals XENE announced that it has submitted a new drug application (NDA) to the FDA for azetukalner,…
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China
HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
Seegene Introduces Syndromic PCR Testing for HPV and STIs in Labs
Seegene Inc announced a syndromic polymerase chain reaction (PCR)-based testing approach for reproductive tract infections through the simultaneous…
An Oral Ketamine Drug for Depression — Minus the Trip?
A novel oral ketamine drug was well tolerated and associated with reduced depressive symptoms in treatment-resistant depression (TRD)…
Could GLP-1 Drugs Reduce Breast Cancer Risk?
GLP-1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention. As reported by The…
Aronia Fruit Extract is Promising Adjunct in Managing Metabolic Syndrome in Older Adults
Metabolic syndrome, characterized by central obesity, dyslipidemia, hypertension, and insulin resistance, is an extensive problem amongst older adults,…